Local Attorney and Corporate Counsel for Ancillare, a Global Clinical and Ancillary Supply Chain Leader, Recognized for Two Professional Commendations

HORSHAM, Pa.–()–Global Clinical and Ancillary Supply Chain leader Ancillare,
—the only organization exclusively serving the end-to-end clinical
and ancillary supply chain management needs of large- and middle-market
pharmaceutical, biotechnology, and medical device companies, as well as
contract and medical research organizations—today announced that David
J. DelCollo, Esq., its primary in-house counsel, has been awarded both
“Top 100 Lawyer” and “Top 40 Under 40” recognitions.

The recognitions come on the heels of DelCollo’s first year as
Ancillare’s general counsel. Prior to joining Ancillare, he served as
Senior Counsel for Bioclinica, where he worked to develop and protect
the company’s intellectual property and licensing rights. DelCollo
brought more than a decade of legal experience in practice areas such as
corporate, contract and healthcare law to Ancillare—knowledge which he
made quick use of, according to Ancillare leadership.

David has made tremendous contributions this year and I think these
awards are apropos,” said Joanne Santomauro, CEO at Ancillare. “He’s a
skilled attorney. Not only as he helped [Ancillare] define our legal
policies, he’s put us on a path to a more secure future.”

Prior to his success in corporate law, DelCollo represented the
Commonwealth in the courtroom. As an Assistant District Attorney in the
Greater Philadelphia Area, he personally prosecuted over 1,000 cases,
winning favorable verdicts and outcomes 97% of the time.

DelCollo holds a J.D. from Widener University School of Law, where he
was a member of the Trial Advocacy team.

The recognition
of “Top 100 Lawyer” was awarded by executive profile publication International
Top 100 Magazine
. DelCollo’s “Top 40 Under 40” spotlight will be
featured a forthcoming 2018 edition of the same magazine.

About Ancillare, LP

Ancillare is the only organization of its kind with a singular focus on
the global clinical and ancillary supply chain. Ancillare arms sponsors
of global clinical trials with a customized, end-to-end Ancillare Supply
Plan, enabling developers of new therapies to optimize their clinical
study supply…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *